跳至主要内容
临床试验/JPRN-jRCT2080220036
JPRN-jRCT2080220036已完成2 期

Exploratory study of rebamipide to evaluate the efficacy and safety in treatment of dry mouth in patients with Sjogren's syndrome

Otsuka Pharmaceutical Co., Ltd.0 个研究点目标入组 104 人开始时间: 2005年9月6日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
104

研究概览

简要总结

With the ability to moderately increase salivation and a good safety profile in patients with Sjogren's syndrome, rebamipide appears to be a promising treatment for dry mouth symptoms in these patients.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Patients with Sjogren's syndrome,
  • 2) patients with dry mouth,
  • 3) patients with decreased salivation,
  • 4) patients aged 20 years or older at time of consent

排除标准

  • 1. Patients who have developed dry mouth clearly due to a cause other than Sjogren's syndrome
  • 2. Patients in whom Saxon test cannot be performed (artificial tooth, tooth implant, etc.)
  • 3. Patients who have received rebamipide within 3 months prior to obtaining informed consent
  • 4. Patients who are pregnant, possibly pregnant, or lactating
  • 5. Patients with a history of hypersensitivity to rebamipide
  • 6. Patients who have received any other investigational drug within 3 months prior to obtaining informed consent
  • 7. Patients who are otherwise judged inappropriate for inclusion in the study by the investigator or subinvestigator

研究者

相似试验

Exploratory Study for Dry Mouth in Patients With... | 临床试验